Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000260948 | SCV000387785 | uncertain significance | Elliptocytosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000316138 | SCV000387786 | uncertain significance | Spherocytosis, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001507849 | SCV001158833 | likely benign | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001507849 | SCV001713668 | uncertain significance | not provided | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003930345 | SCV004739921 | likely benign | SPTB-related disorder | 2022-10-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |